SPR Global Technologies
SPR Global Technologies has succeeded where other organisations – and even governments - have failed, by designing a secure and decentralised Single Patient Record system that will function as intended.
SPR Global Technologies correctly identified the emerging Blockchain technology as being key in the creation of this previously elusive product. Blockchain is currently being utilised to create the decentralised tamper-proof audit trails that make crypto-currencies viable, but SPR Global is implementing Blockchain to make it possible for patient data to be written to, and stored in, a decentralised network of servers. This makes the information both effectively impossible to change thereafter, whilst also being accessible to accredited users.
By combining Blockchain technology with their own secure proprietary software, SPR Global is creating a secure and inviolable personal medical record system that can be accessed and interrogated by patients and medical professionals alike. Every doctor's appointment, pharmacist's prescription, hospital visit - and more - can be recorded by medical professionals using the SPR Global web-based GUI or via an SPR interface with their existing medical system, and accessed thereafter by the patient.
Single Patient Record
The SPR App will do for personal medical records what mobile banking apps have already done for personal financial information. Using the SPR App a person will be able to enter a PIN to log into their personal medical record and search, retrieve, group and display all aspects of their personal medical records in previously impossible detail, via their mobile device. There will also be customisable user functionality.
An update to a medical record by a medical professional will create a node in the Blockchain. That node will be chronologically locked in place and can later be interrogated for information including time, date, medical facility, medical practitioner, procedure, medication, dosage, pharmacist and more.
Patients will also be able to create SPR MicroNodes of their own via accredited health and fitness apps (e.g. MyFitnessPal etc) that track blood pressure, cholesterol levels, body mass index and calorific performance to create a nuanced medical document for use by medical professionals and accredited data end-users.
This product will be introduced as a profile section in the medical professional's user interface, but will grow to become a medical social media platform with complete records of clinician training, qualifications, employment history, published articles, qualifications and certifications. This database will grow to become monetisable to third party end users.
Clinical Data Mine
The implementation of the SPR system will create a vast global database of accurate anonymisable medical data that can be searched and cross-referenced in ways that have never been possible before.
Without compromising patient privacy, medical professionals and organisations adjacent to the medical sector will have access to accurate medical data in ways that are as groundbreaking for them as they are potentially profitable for the provider.
For accredited general practitioners, not only will a patient's entire medical history be accessible during an appointment down to an extreme level of detail, the anonymised data from every SPR user in the world will be available in the form of a database of evolving real-time information that can be cross-referenced using the criteria of the miner's choosing.
Instead of relying on information and assurances based on the limited research carried out by pharmaceutical companies who want their products used, accredited GPs can quickly access real world information based on actual patient experiences, as confirmed by medical professionals.
For example, a patient requires Medication A but they are already taking medications B and C. An accredited GP can quickly access the SPR global database to see how many people taking medications A, B & C together reported side effects within a 6-month period. The GP can then confidently tell the patient that 97% of all patients taking those medications together report no side effects.
Gaining access to the SPR database will help numerous industries immeasurably.
For the pharmaceutical industry the SPR database will be as game changing as digitisation was for the television broadcasters who moved from guessing at viewing figures based on Nielsen families to having completely accurate viewing data. Newly released medications can be tracked for effectiveness and side effects can be monitored, minimising costly recalls and lawsuits.
Health insurance providers, instead of basing fees and services on test groups and estimated actuarial forecasts, can use the SPR database to analyse, assess and react to actual life expectancies and likelihood of illness in different geographic locations, employment categories, age groups etc.
Governmental health bodies will be able to track, compare and contrast the performance of hospitals on the basis of rates of mortality and infection. Situations involving communities being adversely affected by external factors (water or airborne contaminants, industrial pollution, disease outbreaks etc) will be swiftly identified as large numbers of patients present with similar symptoms in one geographic area.
The benefits will be far-reaching and the potential for profits substantial.